Form D · Biotechnology
BaroFold, Inc.
Aurora, CO · CIK 0001484843
Offering snapshot reported Feb 20, 2013 · SEC filing
- Reported sold
- $1.7M Offering amount: $1.7M
- Investors reported
- 25 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Jan 15, 2010 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 20, 2013 | Initial | $1,700,000 | No comparison | 25 | SEC filing |
| Aug 30, 2012 | Initial | $1,450,000 | No comparison | 25 | SEC filing |
| Feb 23, 2010 | Initial | $1,200,000 | No comparison | 22 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 05, 06
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-192147
This is a second amendment to the Form D filed February 22, 2010
Source: Form D, filed Feb 20, 2013. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Matthew Brewer | Director, Executive |
| Josh Fidler | Director |
| William Freytag | Director |
| Kyle Lefkoff | Director |
| Kyle Seefeldt | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
12635 Montview Blvd Suite 217
Aurora, CO, 80045
Aurora, CO, 80045